CARY, N.C., April 28, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today ...

The total value of an artist’s artworks sold at auction over a specific period. This metric reflects the artist’s overall market activity and demand in monetary terms. The middle value of all realized ...

(RTTNews) - Heron Therapeutics Inc. (HRTX) announced that it has appointed Mark Hensley as Chief Operating Officer. He has more than fifteen years of experience in a variety of sales and ...

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced ...

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced ...